An angiotensin II type-I receptor blocker, olmesartan medoxomil, attenuates lipid peroxidation in renal injury induced by subtotal nephrectomy

Clinical and Experimental Nephrology

Volumn 11, Issue 3, 2007, Pages 202-208

  Takahashi, Toshiyuki ^a   Konta, Tsuneo ^a   Takasaki, Satoshi ^a   Ichikawa, Kazunobu ^a   Takeishi, Yasuchika ^a   Kubota, Isao ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Acrolein; Angiotensin II receptor blockade; Malondialdehyde; Nephrectomy

Indexed keywords

4 HYDROXYNONENAL; ACROLEIN; ANGIOTENSIN RECEPTOR ANTAGONIST; LIPID; MALONALDEHYDE; OLMESARTAN; PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MEGADOSE; GLOMERULOSCLEROSIS; GLOMERULUS; IMMUNOHISTOCHEMISTRY; KIDNEY CORTEX; KIDNEY INJURY; KIDNEY PARENCHYMA; KIDNEY TUBULE DISORDER; LIPID PEROXIDATION; LOW DRUG DOSE; MALE; NONHUMAN; OXIDATIVE STRESS; PARTIAL NEPHRECTOMY; PROTEIN BINDING; RAT; RENAL PROTECTION; WESTERN BLOTTING;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BLOOD PRESSURE; BODY WEIGHT; IMIDAZOLES; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY FAILURE; KIDNEY GLOMERULUS; LIPID METABOLISM; LIPID PEROXIDATION; MALE; NEPHRECTOMY; ORGAN SIZE; PROTEINS; RATS; RATS, WISTAR; TETRAZOLES;

EID: 34748923565     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-007-0481-8     Document Type: Article

References (20)

1. S Klahr G Schreiner I Ichikawa 1988 The progression of renal disease N Engl J Med 318 1657 66
2. ND Vaziri Z Ni F Oveisi K Liang R Pandian 2002 Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency Hypertension 39 135 41
3. Q Fan J Liao M Kobayashi M Yamashita L Gu T Gohda 2004 Candesartan reduced advanced glycation end-products accumulation and diminished nitro-oxidative stress in type 2 diabetic KK/Ta mice Nephrol Dial Transplant 19 3012 20
4. T Miyata S Ishikawa K Asahi R Inagi D Suzuki K Horie 1999 2-Isopropylidenehydrazono-4-oxo-thiazolidin-5-ylacetanilide (OPB-9195) treatment inhibits the development of intimal thickening after balloon injury of rat carotid artery: role of glycoxidation and lipoxidation reactions in vascular tissue damage FEBS Lett 445 202 26
5. M Nangaku T Miyata T Sada M Mizuno R Inagi Y Ueda 2003 Anti-hypertensive agents inhibit in vivo the formation of advanced glycation end products and improve renal damage in a type 2 diabetic nephropathy rat model J Am Soc Nephrol 14 1212 22
6. T Konta N Degawa S Kato H Tomoike 1997 Role of transforming growth factor-beta 1 during glomerulosclerosis in rats with reduced renal mass Clin Exp Nephrol 1 187 94
7. K Ikeda Y Nara Y Yamori 1991 Indirect systolic and mean blood pressure determination by a new tail cuff method in spontaneously hypertensive rats Lab Anim 25 26 9
8. DH Kang AH Joly SW Oh C Hugo D Kerjaschki KL Gordon 2001 Impaired angiogenesis in the remnant kidney model: I. potential role of vascular endothelial growth factor and thrombospondin-1 J Am Soc Nephrol 12 1434 47
9. H Takahashi Y Takeishi T Miyamoto T Shishido T Arimoto T Konta 2004 Protein kinase C and extracellular signal regulated kinase are involved in cardiac hypertrophy of rats with progressive renal injury Eur J Clin Invest 34 85 93
10. T Konta Q Xu A Furusu K Nakayama M Kitamura 2001 Selective roles of retinoic acid receptor and retinoid x receptor in the suppression of apoptosis by all-trans-retinoic acid J Biol Chem 276 12697 701
11. D Suzuki T Miyata N Saotome K Horie R Inagi Y Yasuda 1999 Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions J Am Soc Nephrol 10 822 32
12. AB Howard RW Alexander RM Nerem KK Griendling WR Taylor 1997 Cyclic strain induces an oxidative stress in endothelial cells Am J Physiol 272 C421 7
13. K Ranganna Z Yousefipour R Nasif FM Yatsu SG Milton BE Hayes 2002 Acrolein activates mitogen-activated protein kinase signal transduction pathways in rat vascular smooth muscle cells Mol Cell Biochem 240 83 98
14. GM Cahuana JR Tejedo J Jimenez R Ramirez F Sobrino FJ Bedoya 2003 Involvement of advanced lipooxidation end products (ALEs) and protein oxidation in the apoptotic actions of nitric oxide in insulin secreting RINm5F cells Biochem Pharmacol 66 1963 71
15. H Esterbauer RJ Schaur H Zollner 1991 Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes Free Radic Biol Med 11 81 128
16. K Uchida M Kanematsu K Sakai T Matsuda N Hattori Y Mizuno 1998 Protein-bound acrolein: potential markers for oxidative stress Proc Natl Acad Sci USA 95 4882 7
17. HL Xu K Yoshida XM Wu M Kohzuki 2001 Effects of CS-866, an angiotensin II receptor antagonist, in 5/6 nephrectomized spontaneously hypertensive rats (in Japanese) Nippon Jinzo Gakkai Shi 43 580 8
18. C Van den Branden M Gabriels J Vamecq K Vanden Houte D Verbeelen 1997 Carvedilol protects against glomerulosclerosis in rat remnant kidney without general changes in antioxidant enzyme status. A comparative study of two beta-blocking drugs, carvedilol and propanolol Nephron 77 319 24
19. ND Vaziri F Oveisi Y Ding 1998 Role of increased oxygen free radical activity in the pathogenesis of uremic hypertension Kidney Int 53 1748 54
20. HM Kir MO Dillioglugel M Tugay C Eraldemir HK Ozdogan 2005 Effects of vitamins E, A and D on MDA, GSH, NO level and SOD activities in 5/6 nephrectomized rats Am J Nephrol 25 441 6